Treating seizures in Creutzfeldt–Jakob disease
نویسندگان
چکیده
منابع مشابه
Treating seizures in Creutzfeldt–Jakob disease☆
Seizures are known to occur in Creutzfeldt-Jakob disease (CJD). In the setting of a rapidly progressive condition with no effective therapy, determining appropriate treatment for seizures can be difficult if clinical morbidity is not obvious yet the electroencephalogram (EEG) demonstrates a worrisome pattern such as status epilepticus. Herein, we present the case of a 39-year-old man with CJD a...
متن کاملPotential Vaccines for Treating Crohn\'s Disease
Crohn's disease (CD) is an inflammatory disease of the gastrointestinal tract (GIT) tract and can affect several parts of the digestive system. There is a relationship between impaired mucosal barrier in the GIT of inflammatory bowel disease patients and the role of bacteria such as Mycobacterium avium paratuberculosis in CD. Apart from different therapeutic approaches for treating CD, developm...
متن کاملTreating seizures and epilepsy with anticoagulants?
Thrombin is a serine protease playing an essential role in the blood coagulation cascade. Recent work, however, has identified a novel role for thrombin-mediated signaling pathways in the central nervous system. Binding of thrombin to protease-activated receptors (PARs) in the brain appears to have multiple actions affecting both health and disease. Specifically, thrombin has been shown to lead...
متن کاملTreating seizures and preventing amnesia in LGI1-antibody encephalitis
Leucine-rich glioma-inactivated 1 (LGI1)-antibody encephalitis is a treatable disease within the everexpanding group of autoimmune encephalitides. The illness is typically characterized by the subacute onset of amnesia, confusion, and seizures in middle age, with approximately 60% of patients showing medial temporal lobe T2 hyperintensities. The most characteristic seizure syndrome associated w...
متن کاملPerampanel: a selective AMPA antagonist for treating seizures.
Perampanel is a selective, noncompetitive AMPA receptor antagonist that has recently been approved for treating localization-related epilepsy. This article reviews the pharmacology, clinical development, efficacy, and safety/tolerability of perampanel.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Epilepsy & Behavior Case Reports
سال: 2014
ISSN: 2213-3232
DOI: 10.1016/j.ebcr.2014.01.004